Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: 3D Medicines, Applied, Ascletis, Beigene, Bioheng, Biontech, Dizal, Gilead Sciences, Hope Medicines, Ibio, Innovent, Jiangsu Nhwa, Merck, Molecular Targeting Technologies, Neurophth, Oric, Pfizer, Ranok, Sellas Life Sciences, Senhwa, Trevena.